Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

The Cannigma

APRIL 6, 2021

Such limits are not backed by scientific research and should be scrapped, concluded the panel of experts led by the California Highway Patrol. A per se limit for drugs, other than ethanol, should not be enacted at this time as current scientific research does not support it. Drugs affect people differently depending on many variables.

THC 139

THC Research and Development Collective Concentrates 139

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . 20, 2021, from 2:40 – 2:55 p.m.

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JUNE 1, 2021

The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. has emerged as the largest producer and exporter of legalized cannabis for medical and research applications.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. 0:04:45.2] EG: Yeah, we do.

Data 52

Data Patients Access Wellness and Beauty 52

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. We cannot overlook the fact that there is no international law prohibiting the scientific or medical use of cannabis or any other substance. Prohibition Does Not Stop Science.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

NOVEMBER 26, 2019

New Frontier Data is looking to partner with other African nations and deliver similar market assessments and implementation studies, fostering responsible practices and clear understanding of potential socioeconomic impacts of hemp and/or cannabis legalization in traditionally agro-based Sub-Saharan economies.

Data 59

Data Cultivation Hemp Research and Development 59

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

DECEMBER 9, 2021

The study flagship site will be at John Hopkins University (JHU) with research led by Dr. Matthew Johnson. The Company believes the safety and efficacy data collected from the NIDA grant study will support the outcome of their phase 2/3 smoking cessation clinical trial. Advancements in IP and Drug Development.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

DECEMBER 8, 2021

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Stage of development at signing. Alzheimer’s Research UK. AlzProtect.

Access 52

Access Data Pharmaceutical Research and Development 52

Cannabis Law Report

DECEMBER 21, 2021

Heartland’s ‘Hemp4Soil’ program was selected as the recipient of a $360,000 grant over 3 years to develop their soil innovation program. This grant will allow Heartland to partner with farming communities to advance research on soil health and carbon sequestration. Heartland was the only hemp program chosen by the USDA.

Agriculture 52

Agriculture Supply Chain Research and Development Programs 52

NORML

MARCH 7, 2019

Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.

Legislation 249

Legislation Marijuana Policy Research and Development 249

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

MAY 9, 2022

Preferred candidates will have seven years prior experience in a policy-related management role; experience with professional exposure to the cannabis industry or policy issues related to public health and safety; experience with a strong analytical background and experience working with large data sets.

Policy 52

Policy Research and Development Safety Data 52

Cannabis Law Report

JANUARY 21, 2022

Assay”) and Linea™ Unsupervised At-Home Sample Collection Kit (the “Linea Collection Kit”). The Linea Collection Kit is designed to enable the simple self-collection of nasal swab specimens without supervision by medical personnel. COVID-19 Assay (the “Linea 2.0 The Linea 2.0 Investor Relations Contact: Sanjay M.

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

AUGUST 16, 2021

Major Work Duties : Following are some of the major job duties: Conducts technical analysis and evaluations of intelligence data or criminal activity. Interacts with representatives of other law enforcement agencies to exchange information regarding criminals and crimes, utilizing personal contacts, telephone, teletype or other media.

Data 98

Data Research and Development Marijuana Education 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. The Schedule I status attached to cannabis means that it is still a controlled substance under federal law. Their research led them to discover that 5.1% for extracts.

Research and Development 92

Research and Development Agriculture Data Extraction 92

Veriheal

SEPTEMBER 30, 2021

Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis. The team of researchers analyzed data from nearly 20,000 people over a four-year period and found that cannabis use among cancer patients peaked at 9%. Pain Is a Leading Cause of Consumption.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

SMPL

AUGUST 14, 2019

The federal drug scheduling system inhibited research into CBD that the Food and Drug Administration (FDA) is now scrambling to conduct following the legalization of hemp and its derivatives, a top agency official said on Tuesday. It was difficult to research, and it hasn’t been studied nearly as much as we would like.”.

CBD 40

CBD Research and Development Hemp Food 40

Cannabis Law Report

NOVEMBER 23, 2021

to provide naturally derived psilocybin for research and development of therapeutic products. “As the research and drug development work on psilocybin moves forward, HAVN Life continues to position itself as a supply chain leader, able to meet the demand for naturally derived psilocybin,” he adds.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

AUGUST 22, 2021

But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105

Cannabis Law Report

MARCH 10, 2022

Ward and Smith’s Hemp and Cannabis Law attorneys recently attended the fifth annual Industrial Hemp Summit. Breaking from past tradition, this year’s Industrial Hemp Summit was held at the North Carolina Biotechnology Center in the Research Triangle Park. Other Trends and Developments. 10 March 2022. by Erica B.

Hemp 52

Hemp Research and Development Supply Chain Data 52

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

SEPTEMBER 1, 2021

A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages. Looking to develop your career at the forefront of a rapidly expanding industry?

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

Cannabis Law Report

SEPTEMBER 9, 2021

Federal laws were limiting, and taxing cannabis became a way of controlling production. The purpose of this qualitative research study was to explore 5-15 African American entrepreneurs’ perceptions about public policy barriers they face when attempting to enter the cannabis industry. Central Research Question. Recommendations.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.

Safety 52

Safety Hemp Research and Development Data 52

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. Visit [link].

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

AUGUST 18, 2022

Hemp supply chain companies need qualified third-party laboratories that meticulously follow nuanced laws to ensure their products are permissible across the country. With that research, they created elaborate matrices to compare each mandate. End-users also deserve the safest, highest quality products–regardless of where they reside.

Compliance 52

Compliance Compliance Hemp Research and Development 52

Cannabis Law Report

MARCH 21, 2020

Law Enforcement Related to Cannabis. Federal funding has also been provided to support salaries of data analysts who are working closely with PS to develop a set of standardized national indicators on drug-impaired driving, and to prepare regular reports on current issues, trends, and impacts. Background. Current Status.

Safety 88

Safety Research and Development Data Cannabis 88

Cannabis Law Report

AUGUST 10, 2021

Shanti”), and all its assets focused on psychedelic MDMA-based drug development. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.

Safety 52

Safety Hemp Research and Development Data 52